From Yale, Sasha went on to take a position at the University of Washington in Seattle, where he would stay for 16 years, before moving to New York first as
a member of the Immunology Program at the Sloan Kettering Institute and subsequently assuming his current role as the chair of the Immunology Program at the Sloan Kettering Institute and director of the Ludwig Center at the Memorial Sloan Kettering Cancer Center in New York.
Not exact matches
PICI (pronounced «pie - sea»), as it's called by its
member scientists, is doing something unprecedented in academic medicine: combining and coordinating the efforts
of six
of the top cancer
immunology centers in the country — MD Anderson Cancer Center, Memorial Sloan Kettering, Penn Medicine, Stanford, UCLA, and UCSF — in order to greatly expand and, more important, to accelerate our understanding
of why some immune - based treatments work miraculously in some patients and not at all in others.
Other
members include colleagues from various AOECS
Member countries in the fields
of cereal and food technology, dietetics / nutrition, epidemiology, gastroenterology, genetics,
immunology, pathology, paediatrics and psychosocial aspects.
Without that atomic description, «it was impossible to determine how the genome was being sustained through the spread
of the virus,» said Z. Hong Zhou, a professor
of microbiology,
immunology and molecular genetics, a
member of UCLA's California NanoSystems Institute, and a senior author
of the research.
«Until now, this amazing diversity has thwarted efforts to categorize T cell receptors that recognize and respond to the same antigen,» said Paul Thomas, Ph.D., an associate
member of the St. Jude Department
of Immunology.
Still other journals publish work from the
members of their scientific society, such as the American Society for Microbiology's Journal
of Bacteriology or the American Association
of Immunologists» Journal
of Immunology.
«This work demonstrates the feasibility
of using a single gene editing platform, plus the regenerative power
of stem cells to correct genetic mutations and restore dystrophin production for 60 percent
of Duchenne patients,» said Pyle, associate professor
of microbiology,
immunology and molecular genetics and
member of the Broad Stem Cell Research Center.
One
of Beaudet's graduate students — Linyan Meng — was writing her dissertation on Angelman syndrome and was wrestling with this problem when a
member of her dissertation committee, Dr. Thomas Cooper, professor
of pathology &
immunology at Baylor, said he was working with a Carlsbad, Calif. - based company called Isis Pharmaceuticals that had anti-sense oligonucleotides that could turn off the antisense transcript that silenced the paternal copy
of the gene.
Corresponding author Paul Thomas, Ph.D., an associate
member of the St. Jude Department
of Immunology, and Heather Smallwood, Ph.D.,
of the University
of Tennessee Health Science Center in Memphis.
«This study has changed our approach to developing a universal flu vaccine,» said corresponding author Maureen McGargill, Ph.D., an assistant
member of the St. Jude Department
of Immunology.
He is the Harder Family Chair for Cancer Research,
Member and Chief, Laboratory
of Molecular and Tumor
Immunology, at the Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center.
Paulos is an endowed chair in the Department
of Dermatology and Dermatologic Surgery, an associate professor in the Department
of Immunology and a
member of the MUSC Hollings Cancer Center.
Most submitted papers are rated for suitability by
members of Science
Immunology's Advisory Board.
As a
member of the Royal College
of Obstetricians and Gynaecologists, Ashley Moffett, Professor
of Reproductive
Immunology at the University
of Cambridge and expert on placenta formation, said: «We know that the so - called Great Obstetrical Syndromes, in particular pre-eclampsia are more common in older women but it's still not clear why.
«If you can replace a natural population
of dengue - transmitting mosquitoes with genetically modified ones that are resistant to virus, you can stop disease transmission,» says study leader George Dimopoulos, PhD, a professor in the Department
of Molecular Microbiology and
Immunology and a
member of the Johns Hopkins Malaria Research Institute.
Knowing the answer is important both as a matter
of basic
immunology and because NK cells, as crucial
members of the body's first line
of infection defense, are often the subjects
of efforts to harness the immune system in protection against infections and cancer.
«It's not a ban,» says Warner Greene, an IOM committee
member who is director
of the Gladstone Institute
of Virology and
Immunology at the University
of California, San Francisco.
Vahedi is also a
member of Penn's Institute for
Immunology and Epigenetics Institute.
«We want to know what the basic function
of GATA - 3 in regulating cell biology is, although it has been shown that GATA - 3 is important for the function
of CD4 + T cell type to clear extracellular parasites,» said Yisong Wan, PhD, assistant professor
of microbiology and
immunology at the UNC School
of Medicine and
member of UNC Lineberger Comprehensive Cancer Center.
The finding is exciting «because it suggests that the seasonal flu vaccine boosts antibody responses and may provide some measure
of protection against a new pandemic strain that could emerge from the avian population,» said senior study author Paul G. Thomas, PhD, an Associate
Member in the Department
of Immunology at St. Jude.
The study was published in the journal Nature Cell Biology by senior author April Pyle, associate professor
of microbiology,
immunology and molecular genetics and
member of the Eli and Edythe Broad Center
of Regenerative Medicine and Stem Cell Research at UCLA.
«It's HIV going both ways, playing offense and defense,» team
member Warner C. Greene
of the Gladstone Institute
of Virology and
Immunology observes.
Dr. Offit is an internationally recognized expert in the fields
of virology and
immunology, and was a
member of the Advisory Committee on Immunization Practices to the Centers for Disease Control and Prevention.
The research team includes Dr. Masanori Miyata and Dr. Ji - Yun Lee at Georgia State; Dr. Richard A. Flavell, chair
of the Department
of Immunobiology, investigator at the Howard Hughes Medical Institute and a
member of the National Academy
of Sciences at Yale University; Dr. Koichi S. Kobayashi, professor in the Department
of Microbial Pathogenesis and
Immunology at the Texas A&M Health Science Center; and Dr. Hirofumi Kai at Kumamoto University in Japan.
Zhao - Qing Luo, at right, a Purdue professor
of biological sciences and
member of the Purdue Institute for Inflammation,
Immunology and Infectious Diseases, and postdoctoral researcher Jiazhang Qiu look at a petri dish with Legionella pneumophila bacteria.
«We've optimized a vaccine against heroin,» said Kim Janda, a professor in the chemistry and
immunology department at The Scripps Research Institute (TSRI) and a senior
member of the research team.
10.30 - 11.00 Stackebradt, Erko (Professor, Leibnitz Institute, DSMZ - German Collection
of Microorganisms and Cell Cultures; Coordinator, MIRRI - Microbial Resource Research Infrastructure, Braunschweig, Germany): Scientists and (their) microbial resources: responsibilities revisited 11.00 - 11.30 Balázs, Ervin (
Member of HAS, Professor, Director - general, Centre for Agricultural Reserch, Hungarian Academy
of Science, Martonvárár, Hungary): Microbes serving agri - food industry 11.30 - 12.00 Coffee break 12.00 - 12.30 Nagy, Károly (Professor, Institute
of Medical Microbiology, Semmelweis University, Budapest, Hungary): How science supports management
of emerging infections 12.30 - 13.00 Rajnavölgyi, Éva (Professor, Department
of Immunology, University
of Debrecen, Debrecen, Hungary): Human life in invisible company - The significance
of preventive vaccination
William Schief is a Professor in the
Immunology and Microbial Science Department at The Scripps Research Institute in La Jolla, CA, Director for Vaccine Design at the International AIDS Vaccine Initiative (IAVI), and an Associate
Member of the Ragon Institute
of MGH, MIT and Harvard.
On September 1, 2011, Hyam I. Levitsky, M.D., a
member of the executive committee
of the CRI Cancer Immunotherapy Consortium, was named head
of cancer
immunology experimental medicine at Roche, one
of the world's largest pharmaceutical companies.
Other Gladstone colleagues who are also
members of the AAP include Gladstone President, R. Sanders Williams, MD; Senior Investigator and President Emeritus Robert W. Mahley, MD, PhD; Senior Investigator Lennart Mucke, MD, who directs neurological research at Gladstone, and Senior Investigator Eric Verdin involved in virology and
immunology research.
«The cytotoxic chemotherapy can first kill some cancer cells and enhance the sensitivity
of the tumour toward ICB therapy, which then stimulates the effectiveness
of the ICB therapy,» said co-author Gianpietro Dotti, PhD, professor
of microbiology and
immunology at the UNC School
of Medicine and
member of the UNC Lineberger Comprehensive Cancer Center.
He is honored to be back in Ann Arbor as a
member of the Division
of Allergy and Clinical
Immunology.
Members will hear from the Executive Director, the Secretary - Treasurer, the Editors - in - Chief
of AAI journals (The Journal
of Immunology and ImmunoHorizons), and the Chair
of the Committee on Public Affairs on the financial standing
of AAI and other matters
of importance to the membership.
As a
member of the CSI you will be eligible to apply for student, postdoctoral and junior faculty travel awards to the annual Canadian Society for
Immunology meeting as well as travel awards given out every third year to attend the International Congress
of Immunology's annual meeting.
This award recognizes a deserving
member for a remarkable career
of scientific achievement and for contributions to AAI and the field
of immunology.
Professional Societies Italian Society
of Pathology (since 1984,
Member of the Council since 2010), Italian Society
of Immunology (since 1985), British Society for
Immunology (since 1990), American Association
of Immunologists (since 2007), Federation
of the American Socities for Experimental Biology (since 2007).
He is also an associate
member of the Harvard Department
of Molecular and Cellular Biology, and a
member of the Graduate Programs in Biophysics and
Immunology at Harvard University.
Malcolm serves as a
member of the Editorial Boards
of Infection and Immunity (2012 - 17) and Journal
of Advances in Diseases Diagnosis (2014 --RRB- and is a
member of the American Association
of Immunologists, American Society for Microbiology and American Society
of Tropical Medicine and Hygiene, and British Society for
Immunology.
Littman is the Helen L. and Martin S. Kimmel Professor
of Molecular
Immunology, a professor
of pathology and microbiology, and a faculty
member in the Molecular Pathogenesis program in the Skirball Institute for Biomedical Research at the New York University School
of Medicine in New York, NY.
He is a senior
member of the Department
of Immunology of The Netherlands Cancer Institute in Amsterdam, The Netherlands, is a
member of the CRI Scientific Advisory Council, and is a CRI - SU2C Cancer
Immunology Dream Team grantee.
As a
member (and, currently, co-chair)
of the Gladstone Postdoc Advisory Committee, I get to spend more time with people outside
of my own institute (Gladstone Institute
of Virology and
Immunology), and everyone I've met here is a delight to talk to and work with.
«When it comes to translation
of scientific discovery, this is one
of the greatest examples
of the century,» said Dyann Wirth, chair
of the Department
of Immunology and Infectious Diseases at the Harvard T.H. Chan School
of Public Health and a
member of the Alpert Foundation's scientific advisory prize committee.
She is a
member of the Department of Pathology at Brigham and Women's Hospital, an Associate Member at the Broad Institute of MIT and Harvard, and Leader of the Cancer Immunology Program at the Dana - Farber / Harvard Cancer C
member of the Department
of Pathology at Brigham and Women's Hospital, an Associate
Member at the Broad Institute of MIT and Harvard, and Leader of the Cancer Immunology Program at the Dana - Farber / Harvard Cancer C
Member at the Broad Institute
of MIT and Harvard, and Leader
of the Cancer
Immunology Program at the Dana - Farber / Harvard Cancer Center.
Other Academy
members from the Gladstone community include Warner Greene, MD, PhD, Director
of the Gladstone Institute
of Virology and
Immunology, President Emeritus Robert Mahley, MD, PhD, and Gladstone President R. Sanders «Sandy» Williams, MD..
I did postdoctoral fellowships at UCLA and at Scripps Clinic, and then worked at Scripps as an Assistant
Member in the Department
of Immunology.
Founding
member of the British Society for
Immunology.
Susan Amara, USA - «Regulation
of transporter function and trafficking by amphetamines, Structure - function relationships in excitatory amino acid transporters (EAATs), Modulation
of dopamine transporters (DAT) by GPCRs, Genetics and functional analyses
of human trace amine receptors» Tom I. Bonner, USA (Past Core
Member)- Genomics, G protein coupled receptors Michel Bouvier, Canada - Molecular Pharmacology
of G protein - Coupled Receptors; Molecular mechanisms controlling the selectivity and efficacy
of GPCR signalling Thomas Burris, USA - Nuclear Receptor Pharmacology and Drug Discovery William A. Catterall, USA (Past Core
Member)- The Molecular Basis
of Electrical Excitability Steven Charlton, UK - Molecular Pharmacology and Drug Discovery Moses Chao, USA - Mechanisms
of Neurotophin Receptor Signaling Mark Coles, UK - Cellular differentiation, human embryonic stem cells, stromal cells, haematopoietic stem cells, organogenesis, lymphoid microenvironments, develomental
immunology Steven L. Colletti, USA Graham L Collingridge, UK Philippe Delerive, France - Metabolic Research (diabetes, obesity, non-alcoholic fatty liver, cardio - vascular diseases, nuclear hormone receptor, GPCRs, kinases) Sir Colin T. Dollery, UK (Founder and Past Core
Member) Richard M. Eglen, UK Stephen M. Foord, UK David Gloriam, Denmark - GPCRs, databases, computational drug design, orphan recetpors Gillian Gray, UK Debbie Hay, New Zealand - G protein - coupled receptors, peptide receptors, CGRP, Amylin, Adrenomedullin, Migraine, Diabetes / obesity Allyn C. Howlett, USA Franz Hofmann, Germany - Voltage dependent calcium channels and the positive inotropic effect
of beta adrenergic stimulation; cardiovascular function
of cGMP protein kinase Yu Huang, Hong Kong - Endothelial and Metabolic Dysfunction, and Novel Biomarkers in Diabetes, Hypertension, Dyslipidemia and Estrogen Deficiency, Endothelium - derived Contracting Factors in the Regulation
of Vascular Tone, Adipose Tissue Regulation
of Vascular Function in Obesity, Diabetes and Hypertension, Pharmacological Characterization
of New Anti-diabetic and Anti-hypertensive Drugs, Hypotensive and antioxidant Actions
of Biologically Active Components
of Traditional Chinese Herbs and Natural Plants including Polypehnols and Ginsenosides Adriaan P. IJzerman, The Netherlands - G protein - coupled receptors; allosteric modulation; binding kinetics Michael F Jarvis, USA - Purines and Purinergic Receptors and Voltage-gated ion channel (sodium and calcium) pharmacology Pain mechanisms Research Reproducibility Bong - Kiun Kaang, Korea - G protein - coupled receptors; Glutamate receptors; Neuropsychiatric disorders Eamonn Kelly, Prof, UK - Molecular Pharmacology
of G protein - coupled receptors, in particular opioid receptors, regulation
of GPCRs by kinasis and arrestins Terry Kenakin, USA - Drug receptor pharmacodynamics, receptor theory Janos Kiss, Hungary - Neurodegenerative disorders, Alzheimer's disease Stefan Knapp, Germany - Rational design
of highly selective inhibitors (so call chemical probes) targeting protein kinases as well as protein interaction inhibitors
of the bromodomain family Andrew Knight, UK Chris Langmead, Australia - Drug discovery, GPCRs, neuroscience and analytical pharmacology Vincent Laudet, France (Past Core
Member)- Evolution
of the Nuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation
of G protein - coupled receptors Richard Neubig, USA (Past Core
Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function
of GABA - A receptors; mode
of action
of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core
Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation
of expression and function
of the ATP - binding cassette (ABC) transporters
Welcome to the second installment
of our new regular monthly slot where we report on research from the world
of immunology, highlighting work from BSI
members that has hit the headlines over the past four weeks.
Writing in Journal
of Immunology, lead author and BSI
member, Professor Graham Anderson explains, «Post-transplantation, T - cell progenitors derived from the bone marrow transplant can struggle to enter the thymus, as if the doorway to the thymus is closed.
Welcome to our sixth installment
of our new regular monthly slot where we report on research from the world
of immunology, highlighting work from BSI
members that has hit the headlines over the past four weeks.